Gene Query: MRPL39

Dataset Description Geneva Score
TCF7L1 knockdown in pancreatic cancer 37.01
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 25.4
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 24.14
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 17.1
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 16.74
Comprehensive comparative analysis of 5’ end RNA sequencing methods 14.96
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 14.34
Gene expression changes caused by KRAS in MCF-10A 12.46
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 12.03
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 11.33
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 11.33
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 11.32
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 11.27
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 11.25
ETS family proteins bind glucocorticoid receptor: relevance for treatment of Ewing sarcoma 9.38
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 9.25
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 8.81
ETV7 and interferon response 8.81
Regulation of mRNA half-life by an inhibitor of human decapping enzyme Dcp2 following transcription shutoff in HEK293T cells 8.62
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 8.33
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 8.3
Lysine benzoylation is a novel histone mark [RNA-seq] 8.22
Lysine benzoylation is a novel histone mark 8.22
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 8.13
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor 7.63
Development of a selective CDK9 degrader from a multi-targeted CDK inhibitor [RNA-seq] 7.63
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 7.6
ZNF599 and DNMT3A coordinately control nuclear envelope organization by repression of SUN4 expression 7.38
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 7.34
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 7.22
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 7.11
The dynamics of cellular response to therapeutic perturbation using multiplexed quantification of the proteome and transcriptome at single-cell resolution 6.94
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 6.91
A Reproducibility-Based Computational Framework Identifies An Inducible, Enhanced Antiviral Dendritic Cell State In HIV-1 Elite Controllers (TLR perturbation Bulk RNA-Seq) 6.91
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 6.85
Transcription control by the ENL YEATS domain in acute leukemia 6.85
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 6.73
DART-seq: an antibody-free method for global m6A detection 6.69
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.65
Domain-focused CRISPR-screen identifies HRI as a fetal hemoglobin regulator in human erythroid cells 6.62
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 6.57
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 6.57
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.57
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 6.54
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 6.35
Integrative Genomic Analysis Reveals Widespread Enhancer Regulation by p53 in Response to DNA Damage 6.32
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 6.27
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 6.19
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 6.17
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion [12Z_RNA-seq] 6.1
Transcriptional profile of human STAT1-/- fibroblasts expressing IFI6 or empty control vector 6.03
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.97
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 5.88
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 5.88
Transcriptome analysis upon C6orf203 silencing 5.87
Tracking distinct RNA populations using efficient and reversible covalent chemistry 5.86
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 5.84
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 5.74
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 5.72
Perlman syndrome nuclease DIS3L2 controls cytoplasmic non-coding RNAs and provides surveillance pathway for maturing snRNAs 5.72
Expression by CD133+ cells isolated from the adult human exocrine pancreas 5.67
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 5.64
Sequencing Universal Human Reference RNA by Smart-seq and early barcoding library preparation methods 5.63
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 5.56
Developmental stage specific chromosome architecture in human erythroid cells 5.56
Treatment of SW480 colon cancer cell induced xenografts with AZD and DBZ 5.56
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 5.53
Trans-differentiation of human adult peripheral blood T cells into neurons 5.52
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 5.48
Effects of NSUN2 deficiency on the mRNA 5-methylcytosine modification and gene expression profile in HEK293 cells (RNA-Seq) 5.41
Absence of NKG2D ligands defines human leukaemia stem cells and mediates their immune evasion 5.37
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 5.35
RNA-seq of HDAC2-disrupted 293FT cells by CRISPR-Cas9 5.33
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 5.31
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 5.25
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 5.24
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 5.24
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 5.22
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 5.22
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 5.18
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 5.15
Gene-Centric Functional Dissection of Human Genetic Variation Uncovers Regulators of Hematopoiesis 5.11
Systematic discovery of endogenous human ribonucleoprotein complexes 5.08
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 4.98
RNAseq of HEK293 cells after Chtop knockdown 4.96
Co-transcriptional loading of RNA export factors shapes the human transcriptome 4.96
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.96
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 4.95
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 4.91
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 4.9
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 4.9
Knockdown of ADNP in HCT116 colon cancer cells 4.84
LNCaP treated with iBET 4.83
The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion 4.81
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 4.8
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 4.76
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.74
Cajal bodies are linked to genome conformation 4.74
Cajal bodies are linked to genome conformation [RNA-Seq] 4.74
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 4.72
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 4.72
Image based identification and targeting of cancer stem cells in pancreatic adenocarcinoma (PDAC) 4.7
RNA-Seq comparative analysis of human neuroblastoma cells before and after their confrontation to the embryonic microenvironment 4.7
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 4.69
Induction of human hemogenesis in adult fibroblasts by defined factors and hematopoietic co-culture 4.65
FBXW7 modulates stress response by post-translational modification of HSF1 4.63
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 4.63
The Human Testis Cell Atlas via Single-cell RNA-seq 4.62
Chronophin regulates metabolic and transcriptomic features of glioblastoma stem-like cells 4.61
Dynamic epigenetic remodeling underlies microRNA-mediated transdifferentiation of human adult fibroblasts into neuronal subtypes 4.61
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype [RNA-Seq] 4.61
Bromodomain-containing Protein 4 (BRD4) is Required for the Maintenance of a Mammary Epithelial Phenotype 4.61
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 4.6
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 4.59
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 4.59
Integration of kinase and calcium signaling at the level of chromatin underlines inducible gene activation in T cells 4.55
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 4.53
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 4.51
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 4.48
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 4.43
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 4.43
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 4.42
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 4.42
Primary Human B-cell Temporal Response to CD40L Stimulation 4.4
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 4.32
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 4.29
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 4.28
Gene expression profiles in response to proanthocyanidins in pancreatic cancer cells 4.27
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 4.27
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 4.24
Transcriptome analysis of dominant-negative Brd4 mutants identifies Brd4-specific target genes of BET inhibitor JQ1 4.23
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 4.22
MOF acetyl transferase regulates transcription and respiration in mitochondria 4.17
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 4.14
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis [RNA-Seq] 4.11
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.11
A transcriptome-wide divergence in protein translation scales with LIN28B expression 4.11
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 4.1
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 4.1
HMGA2 Promotes Long-Term Engraftment and Myelo-Erythroid Differentiation of Human Hematopoietic Stem and Progenitor Cells 4.09
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 4.04
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy 4.0
Transcriptional impact of MTHFD2 in Human Aortic Endothelial Cells 3.99
The translation termination factor GSPT1 is a phenotypically relevant off-target of heterobifunctional phthalimide degraders 3.99
Crizotinib v. DMSO in SW480 cells 3.91
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 3.89
Single-cell RNA Sequencing Resolves Spatiotemporal Development of Pre-thymic Lymphoid Progenitors and Thymus Organogenesis in Human Embryos 3.88
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.88
The cohesin complex prevents Myc-induced replication stress 3.82
The Genetic Landscape of Diamond-Blackfan Anemia 3.82
Profiling of protrusion-enriched RNAs from human breast cancer cell line MDA-MB-231 3.81
EWS-Fli and LNC regulated genes in comparison to GFP samples 3.8
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 3.8
Seletive inhibition of CDK9 in DLBCL cell lines 3.79
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.77
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 3.76
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 3.76
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 3.76
A Unique Epigenomic Landscape Defines Human Erythropoiesis 3.74
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 3.74
SLIGRL-induced gene expression changes in NHEK cells 3.74
High throughput characterization of the m6A demethylase FTO by CLIP and RNAseq 3.73
Next Generation Sequencing of human SMA and healthy control Motor Neurons 3.71
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 3.71
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 3.69
Mapping interactions for the TNIP2 hub protein 3.68
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 3.68
Effect of from Human Umbilical Vein Endothelial Cells 3.65
Dynamic incorporation of histone H3 variants into chromatin is essential for acquisition of aggressive traits and metastatic colonization 3.64
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 3.62
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 3.59
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 3.59
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 3.59
Vitamin d receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy 3.58
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 3.56
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 3.52
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 3.52
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.51
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 3.48
JunB control of keratinocyte-mediated inflammation [RNA-seq] 3.48
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 3.48
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 3.48
Hijacking of stress response machinery by oncogenes in acute leukaemia 3.48
Single cell analysis of HSV-1 infection reveals anti-viral and developmental programs are activated in distinct sub-populations with opposite outcomes 3.47
Contribution of synergism between PHF8 and HER2 signalling to breast cancer development and drug resistance  3.45
The landscape of alternative splicing in aggressive prostate cancers 3.44
mRNA-seq from Nutlin-3a, doxorubicin, and DMSO treated HCT116 p21-/- cells 3.43
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 3.43
Expression changes in melanoma cell lines under BRAFi treatment timepoints [RNA-Seq.CellLine.batch4] 3.42
RNA-seq of PC3 prostate cancer cell line xenografts in mice administered the ghrelin receptor antagonist [D-Lys3]-GHRP-6 or PBS for two weeks 3.41
Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidies 3.4
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 3.4
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 3.37
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 3.37
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.36
An optimization system for isolating and sequencing of single human colon cancer cells 3.35
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.35
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 3.34
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 3.34
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [NALM6 RNA-Seq] 3.27
TGF-b-activated LncRNA LINC00115 is a critical regulator for glioma stem-like cell tumorigenicity 3.22
Global transcriptome analysis of HAP1 cells 3.2
A single-cell atlas of the human cortex reveals drivers of transcriptional changes in Alzheimer’s disease in specific cell subpopulations 3.19
MYC dependent mRNA translation shapes gene expression and cell biology 3.17
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 3.17
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 3.17
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 3.16
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (RNA-seq dataset) 3.15
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements 3.14
MenSCs inhibit HCC growth through oncogenic pathway suppression via regulating 5-hmC in enhancer elements [RNA-seq] 3.14
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 3.14
Epigenetic Therapy Increases Therapeutic Efficacy in Myeloproliferative Neoplasms Through Inhibition of Aberrant Inflammatory Signaling 3.11
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 3.09
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.09
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 3.07
Spliceosomal disruption of the non-canonical BAF complex in cancer 3.05
Effect of CHKA knockdown on C4-2 cell transcriptome 3.04
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 3.04
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 3.04
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 3.03
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 3.03
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines [RNA-seq] 3.02
Mapping of DHT-responsive or -independent AR-binding sites induced by activated Src in prostate cancer cell lines 3.02
RNA-seq data 2.97
Oncogenic MYC induces a dependency on the spliceosome in human cancer 2.96
Human Treg IL-12 stimulation 2.94
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 2.94
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 2.92
Human CD4+CD103+ cutaneous resident memory T cells are found in the circulation of healthy subjects 2.92
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 2.9
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 2.9
The conserved transcriptional landscapes in human spermatogenesis 2.89
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 2.87
Uridylation by TUT4 and TUT7 marks mRNA for degradation 2.85
The LINC01138 Drives Malignancies via Activating Arginine Methyltransferase 5 in Hepatocellular Carcinoma 2.85
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 2.79
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.78
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 2.78
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 2.78
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 2.77
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 2.76
Discovering human diabetes-risk gene function with genetics and physiological assays 2.74
Solid phase chemistry to covalently and reversibly capture thiolated RNA 2.72
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.72
N6-methyladenine DNA Modification in Glioblastoma 2.72
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 2.72
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.71
Plasma cell mitochondrial pyruvate import controls the duration of humoral immunity. 2.7
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 2.69
Regulation of protein translation during mitosis 2.65
Gene expression signatures of innate lymphoid cells from human blood 2.63
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 2.62
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 2.62
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.62
Impact of library preparation on downstream analysis and interpretation of RNA-seq data: comparison between Illumina PolyA and NuGEN Ovation protocol 2.61
Single-cell Map of Diverse Immune Phenotypes in the Breast Tumor Microenvironment - 5' RNA sequencing and TCR sequencing 2.61
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.57
RNA-seq of YB5 cells treated with Proscillaridin A 2.51
B cells expressing the IgA receptor FcRL4 participate in the autoimmune response in patients with rheumatoid arthritis 2.5
RNA editing in nascent RNA affects pre-mRNA splicing 2.49
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 2.49
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 2.49
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 2.49
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 2.49
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 2.48
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 2.46
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 2.45
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.44
The cytokine environment influence on human skin-derived T cells 2.43
RNA-seq analysis of HT-29, MCF10A, and MDA-MB-436 cells 2.43
Zone dependent distinctive gene expression profile of the normal human liver tissue 2.43
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 2.41
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 2.38
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.36
Antioxidant metabolism in activated CD8+ T cells regulates stem-like human memory T cell formation and anti-tumor immunity 2.36
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 2.35
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.33
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.32
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.29
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 2.26
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs 2.24
MOV10 Is a 5' to 3' RNA Helicase Contributing to UPF1 mRNA Target Degradation by Translocation along 3'UTRs (expression) 2.24
PRDM1 inhibits proliferation of human colon cancer organoids 2.23
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 2.22
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 2.22
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 2.2
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 2.2
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.2
TOP2B disturbed the quality of human oocytes with advanced maternal age 2.19
RNA-seq analysis of control and Myc-induced U2OS cells 2.19
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 2.17
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 2.17
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 2.17
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 2.16
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 2.1
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 2.09
Transcriptome sequencing of K-562 cells 2.05
Human Treg IFNg/IL-10 subpopulations 2.04
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 2.04
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 2.01
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 2.01
Transcriptional landscape changes during human embryonic stem cell derivation 2.01
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies [RNA-Seq] 2.0
Incomplete MyoD-induced transdifferentiation is mediated by chromatin remodeling deficiencies 2.0
Comparing effects of perfusion and hydrostatic pressure on human chondrocytes using gene profiles 2.0
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.97
Transcriptome analysis of human immortilized astrocytes reprogrammed into dopaminergic neurons 1.96
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 1.96
Human bone marrow resident natural killer cells have a unique transcriptional profile and resemble resident memory CD8+ T cells 1.95
RNA-Seq data of NCI-H82 cells expressing a Dox-On pRB (pTripZ RB1) grown in the presence or absence of DOX and then treated with vehicle or AZD2811. 1.95
Investigsting the role of NF-ĸB p50 S80 phosphorylation in regulating TNFα-induced transcription in HEK293T cells 1.94
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.91
Total RNA-seq in ALL-SIL upon TLX1 knockdown 1.9
UPF1/SMG7-dependent MicroRNA-mediated Gene Regulation 1.9
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.88
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 1.87
Genome-wide analysis of the Integrator complex (HTS) 1.87
Genome-wide analysis of the Integrator complex 1.87
RNA-sequencing of human mammary epithelial cells (HMLEs) engineered to express either ER or ER-SOX4 with and without 4-OHT to induce nuclear translocation 1.87
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 1.86
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.82
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.82
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.79
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 1.78
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 1.76
Gene expression analysis upon mtDNA depletion 1.76
Gene expression analysis upon mtDNA depletion [RNA-seq] 1.76
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 1.74
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing [RNA-Seq] 1.73
Abnormal RNA splicing and genomic instability after induction of DNMT3A mutations by CRISPR/Cas9 gene editing 1.73
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 1.72
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 1.72
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 1.72
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line 1.72
Ribosome profiling upon inhibition of eIF4A 1.71
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 1.7
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.7
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 1.7
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.7
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 1.69
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 1.69
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 1.68
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.68
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.68
scRNASeq analysis of cycling cardiomyocytes 1.64
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.64
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.62
β-Caryophyllene Enhances the Transcriptional Upregulation of SREBP-dependent Lipid Biosynthesis in Breast Cancer Cells 1.61
Genome-Wide Specificity of DNA-Binding, Gene Regulation, and Chromatin Remodeling by TALE- and CRISPR/Cas9-Based Transcription Factors 1.6
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia 1.6
Chromatin Topology Reorganization and Transcription Repression by PML/RARα in Acute Promyeloid Leukemia (RNA-seq) 1.6
Functional significance of the HIV-1 Tat signature amino acid residues 1.59
Genome-wide transcriptional response to random aneuploidy in human cells 1.58
Gene expression analysis of CD4+ and CD4- ILC1 subsets by RNAseq 1.58
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 1.57
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 1.55
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 1.54
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 1.54
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 1.54
Expression analysis of PC3 cells treated with scramble AON or AON directed against MBNL1 1.54
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.51
JAK dependent survival of ALK- ALCL 1.49
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 1.49
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 1.49
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 1.49
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 1.49
Binding to SMN2 pre-mRNA-Protein complex elicits specificity for small molecule splicing modifiers 1.48
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.46
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.45
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 1.45
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 1.45
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 1.45
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.43
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 1.42
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 1.38
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.38
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 2] 1.34
Role of FGFR1 in neuronal devlopment 1.31
Identifying markers predicting successful graft outcome for clinical translation of hESC-based cell therapy for Parkinson’s disease 1.31
Functional Inflammatory Profiles Distinguish Myelin-Reactive T Cells from Patients with Multiple Sclerosis 1.3
SETBP1-WT and SETBP1-G870S epigenetic landscapes 1.29
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 1.29
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 1.29
The impact of stanniocalcin 1 on the transcriptome of human cord blood stem/progenitors 1.26
RNA sequencing with KSHV infection and enrichment for circular RNAs 1.25
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 1.24
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 1.24
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 1.21
Transcriptional response of human endocervical epithelial A2EN cells to infection with wild-type or CpoS-deficient Chlamydia trachomatis L2/434/Bu 1.2
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.2
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 1.19
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 1.14
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 1.14
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.14
High-throughput sequencing of the human hepatic progenitor cell niche in PSC and HCV. 1.14
single cell RNA-seq from GM12878 (ENCSR673UIY) 1.13
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 1.13
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 1.12
Primate transcript and protein expression levels evolve under compensatory selection pressures 1.12
Carcinoma-astrocyte gap junctions promote brain metastasis by cytosolic dsDNA response transfer 1.11
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.11
The p30 isoform of CEBPA uncovers a silent enhancer to drive the expression of the tumor promotive factor CD73 in CEBPA mutant AML 1.1
Impact on erythroid progenitor type on erythroid differntiation 1.09
Low carbohydrate diet study for non-alcoholic fatty liver disease patients 1.09
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 1.01
Chromatin landscape of human visceral and subcutaneous adipocytes 0.99
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.96
Transcriptome profiling of HepG2 cells upon treatment of the menin-MLL inhibitor MI-503 or DMSO 0.96
Ro60-knockout cells 0.94
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 0.94
Overexpression of Claspin and Timeless protects cancer cells from replication stress in a checkpoint-independent manner 0.93
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 0.92
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.91
Enhancement of Human B Cell Differentiation and Function in Lymph Nodes by the TLR9 Agonist MGN1703 0.9
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 0.89
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 0.88
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.88
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.88
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.87
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 0.87
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 0.82
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.81
An integrative analysis of non-coding regulatory DNA variations associated with autism 0.79
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.79
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 0.79
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 0.79
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 0.78
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.77
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.77
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 0.76
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 0.76
Exploiting Prmt5-orchestrated intron detention signatures to treat splicing-addicted malignant glioma tumors 0.73
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.72
RNA-seq of human foreskin fibroblast cells lacking RB, p130, and p107 treated with doxorubicin. 0.71
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 0.7
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 0.68
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 0.68
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.67
RNA-seq of Single-Cell Genotyping of Transcriptomes 0.67
Single-Cell Genotyping of Transcriptomes 0.67
Changes in CD34 and Erythroid Progenitor Transcriptome After RUNX3 Kock-down 0.66
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.65
p53 activity results in DNA replication fork processivity 0.62
Transcriptome-wide analysis links the short-term expression of the b isoforms of T-cell intracellular antigens to protective proteostasis-mediated survival and quiescence 0.62
O-glcnAc reprograms cellular energetics 0.61
JUNB is a critical AP1 component for SMAD2/3 binding after TGFβ stimulation [RNA-seq] 0.6
SMAD2/3 are redirected to novel sites in MCF10A MII after prolonged TGFβ stimulation 0.6
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.59
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 0.59
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.58
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.58
RNA-seq analysis of control and ZC3H18-depleted ovarian cancer cells 0.57
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution 0.55
Deciphering the ‘m6A code’ via quantitative profiling of m6A at single-nucleotide resolution [III] 0.55
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 0.49
RNA-seq of IL-4 stimulated human keratinocytes 0.49
siRNA-mediated knockdown 0.47
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 0.42
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 0.38
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 0.38
Global transcriptome analysis of WT versus HEB-/- hESCs 0.37
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 0.37
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.36
Mutational landscape of aggressive natural killer-cell leukemia and drug profiling highlight JAK-STAT signaling as a therapeutic target in NK-cell malignancies 0.34
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 0.31
Measuring the effect of MYC on transcription during the DNA double-strand break response by RNA-seq of newly synthesized transcripts 0.31
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 0.3
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 0.3
RNASeq of Healthy Human Skin Tregs and CD4 Teffs versus Psoriatic Human Skin Tregs and CD4 Teffs 0.29
High-resolution comparative analysis of great ape genomes 0.28
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 0.27
Single-Cell reconstruction of differentiation trajectory reveals essential dynamics in human cardiac lineage commitment 0.27
Pseudotime Ordering of Single Human Beta-Cells Reveals States of Insulin Production and Unfolded Protein Response 0.26
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.24
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.21
Identification and mitigation of pervasive off-target activity in CRISPR-Cas9 screens for essential non-coding elements 0.21
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 0.18
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.18
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.16
Modulation of nonsense-mediated decay by rapamycin 0.16
Characterizing smoking-induced transcriptional heterogeneity in the human bronchial epithelium at single-cell resolution 0.15
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.11
HEK293 TFAM Knockout Expression Study 0.11
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.1
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.1
Transcriptional profiling of SF295 cells following MTF1 knockout by CRISPR/Cas9 0.1
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.1
Human Treg NaCl stimulation 0.09
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates 0.07
Remodeling of Ago2-mRNA interactions upon cellular stress reflects miRNA complementarity and correlates with altered translation rates (part 4) 0.07
Poly(ADP-ribose) polymerase 1 is necessary for coactivating hypoxia-inducible factor-1-dependent gene expression by Epstein-Barr virus latent membrane protein 1 0.07
Function and hormonal regulation of GATA3 in human first trimester placentation 0.06
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.06
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 0.05
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 0.04
The bromodomain protein BRD4 regulates splicing during heat shock 0.04
CD133hi, Notchhi, DP (double positive) and DN (double negative) in GBML8 and GBML20, both patient-derived glioblastoma tumorsphere cultures 0.04
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 0.01
RNA seq analysis of human Fetal and adult derived Enterospheres 0.01
Apoptosis enhancing drugs overcome innate platinum resistance in CA125 negative tumor initiating populations of high grade serous ovarian cancer 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation